Results of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial by stroke subtypes

Pierre Amarenco, Oscar Benavente, Larry B. Goldstein, Alfred Callahan, Henrik Sillesen, Michael G. Hennerici, Steve Gilbert, Amy E. Rudolph, Lisa Simunovic, Justin A. Zivin, K. Michael A. Welch

Producción científica: Articlerevisión exhaustiva

227 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Results of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial by stroke subtypes'. En conjunto forman una huella única.

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Engineering